Ken Griffin X Biotech Inc. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in X Biotech Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 200 shares of XBIT stock, worth $624. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Holding current value

$624

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.8 - $8.25 $49 - $107	13 New	13 $0
Q2 2024 Aug 14, 2024	SELL	$4.54 - $9.89 $9,770 - $21,283	-2,152 Reduced 30.56%	4,890 $25,000
Q1 2024 May 15, 2024	SELL	$4.03 - $8.13 $21,084 - $42,536	-5,232 Reduced 42.63%	7,042 $57,000
Q4 2023 Feb 14, 2024	BUY	$3.56 - $4.65 $5,770 - $7,537	1,621 Added 15.22%	12,274 $49,000
Q3 2023 Nov 14, 2023	SELL	$4.02 - $5.81 $23,902 - $34,546	-5,946 Reduced 35.82%	10,653 $43,000
Q2 2023 Aug 14, 2023	SELL	$3.06 - $6.38 $11,551 - $24,084	-3,775 Reduced 18.53%	16,599 $98,000
Q1 2023 May 15, 2023	BUY	$3.22 - $4.72 $27,849 - $40,823	8,649 Added 73.77%	20,374 $70,000
Q4 2022 Feb 14, 2023	BUY	$3.03 - $3.79 $35,526 - $44,437	11,725 New	11,725 $41,000
Q2 2022 Aug 15, 2022	BUY	$5.13 - $9.2 $203,224 - $364,458	39,615 Added 95.99%	80,884 $455,000
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $56,669 - $76,805	-6,559 Reduced 13.71%	41,269 $356,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $470,874 - $663,224	36,361 Added 317.09%	47,828 $619,000
Q3 2020 Nov 16, 2020	BUY	$13.97 - $21.16 $160,193 - $242,641	11,467 New	11,467 $219,000
Q2 2020 Aug 14, 2020	SELL	$10.39 - $16.07 $354,652 - $548,533	-34,134 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.89 - $24.94 $132,523 - $371,780	14,907 Added 77.53%	34,134 $363,000
Q2 2019 Aug 14, 2019	BUY	$6.99 - $11.27 $134,396 - $216,688	19,227 New	19,227 $146,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.7M

Call Options Held

200

Put Options Held

12.8K

Black Rock Inc. New York, NY

1.13M
Shares

$3.54 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.06M
Shares

$3.32 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

455K
Shares

$1.42 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

264K
Shares

$822,188
0.0% of portfolio
Credit Suisse Ag Zurich, V8

248K
Shares

$774,602
0.0% of portfolio

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $95M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account